As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center) that ...

New data indicate that nonoperative surveillance after removing a malignant colorectal polyp can achieve high rates of rectal ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...

Many people associate colon cancer with old age, but that's not the case anymore, as the number of young people being diagnosed is on the rise. According to the American Cancer Society, an estimated ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

Sarah Basore, an Overland Park resident who is living with Stage 4 colon cancer, began clinical trials in August, which require weekly drives to Nashville. The current regime has stabilized her ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

"If I would have known that so many young people were getting diagnosed with colon cancer, I would have taken the symptom more seriously," Meagan Meadows said Charna Flam is a writer-reporter at ...

Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune hubs and shrink colon cancer in mice, opening the door to “living medicines” ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...